Accelerated Pharma (Accelerated Pharma) Long-Term Debt : $1.23 Mil (As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Long-Term Debt?

Accelerated Pharma's Long-Term Debt for the quarter that ended in Mar. 2017 was $1.23 Mil.

Accelerated Pharma's quarterly Long-Term Debt increased from Sep. 2016 ($1.11 Mil) to Dec. 2016 ($1.21 Mil) and increased from Dec. 2016 ($1.21 Mil) to Mar. 2017 ($1.23 Mil).

Accelerated Pharma's annual Long-Term Debt declined from Dec. 2014 ($0.36 Mil) to Dec. 2015 ($0.00 Mil) but then increased from Dec. 2015 ($0.00 Mil) to Dec. 2016 ($1.21 Mil).

Accelerated Pharma Long-Term Debt Historical Data

The historical data trend for Accelerated Pharma's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Long-Term Debt Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Long-Term Debt

0.36

1.21

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Long-Term Debt	Get a 7-Day Free Trial			-	0.42	1.11	1.21	1.23

Accelerated Pharma (NAS:ACCP) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Accelerated Pharma Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines